Achieving glycemic control in special populations in hospital: Perspectives in practice

Canadian Journal of Diabetes

Volumn 38, Issue 2, 2014, Pages 134-138

  Cheng, Alice Y Y ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes; Enteral feeding; Glucorticoids; Glycemic control; In hospital; Parenteral feeding; Steroids; Total parental feeding (TPN)

Indexed keywords

DEXAMETHASONE; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN; METHYLPREDNISOLONE; PIG INSULIN; PREDNISOLONE; PREDNISONE; ANTIDIABETIC AGENT; GLUCOCORTICOID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; CYSTIC FIBROSIS; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMATOLOGIC MALIGNANCY; HOSPITAL CARE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MORNING DOSAGE; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; ADULT; BLOOD; DIABETES MELLITUS; DIABETIC DIET; FEMALE; HOSPITAL PATIENT; MALE; METABOLISM; PROCEDURES;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC DIET; ENTERAL NUTRITION; FEMALE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; MALE; PARENTERAL NUTRITION; RISK ASSESSMENT;

EID: 84897015898     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.02.021     Document Type: Article

References (35)

1. Houlden R., Capes S., Clement M., Miller D. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: in-hospital management of diabetes. Can J Diabetes 2013, 37(suppl 1):S77-S81.
2. Umpierrez G.E., Hellman R., Korytkowski M.T., et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. JClin Endocrinol Metab 2012, 97:16-38.
3. Draznin B., Gilden J., Golden S.H. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013, 36:1807-1814. Inzucchi SE for the PRIDE investigators.
4. Cheung N.W., Napier B., Zaccaria C., Fletcher J.P. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 2005, 28:2367-2371.
5. Clement S., Braithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27:553-591.
6. Ziegler T.R. Parenteral nutrition in the critically ill patients. NEngl J Med 2009, 361:1088-1097.
7. Pasquel F.J., Spiegelman R., McCauley M., et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care 2010, 33:739-741.
8. Sarkisian S., Fenton T.R., Shaheen A.A., Raman M. Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality. CanJ Gastroenterol 2010, 24:453-457.
9. Lin L.Y., Lin H.C., Lee P.C., et al. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 2007, 333:261-265.
10. Yan C.L., Huang Y.B., Chen C.Y., et al. Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition. Acta Anaesthesiol Taiwan 2013, 51:67-72.
11. Mesotten D., Van den Berghe G. Glycemic targets and approaches to management of the patient with critical illness. Curr Diabetes Rep 2012, 12:101-107.
12. Marik P.E., Preiser J.C. Toward understanding tight glycemic control in the ICU: a systematic review and meta-analysis. Chest 2010, 137:544-551.
13. Gosmanov A.R., Umpierrez G.E. Management of hyperglycemia during enteral and parenteral nutritional therapy. Curr Diabetes Rep 2013, 13:155-162.
14. Cresci G. Targeting the use of specialized nutritional formulas in surgery and critical care. JParen Ent Nutr 2005, 29:S92-S95.
15. Korytkowski M.T., Salata R.J., Koerbel G.L., et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 2009, 32:594-596.
16. Fatati G., Mirri E., Del Tosto S., et al. Use of insulin glargine in patients with hyperglycaemia receiving artificial nutrition. Acta Diabetol 2005, 42:182-186.
17. Oliveira G., Tapia M.J., Ocon J., et al. Parenteral nutrition-associated hyperglycemia in non-critically ill inpatients increases the risk of in-hospital mortality (multicenter study). Diabetes Care 2013, 36:1061-1066.
18. McClave S.A., Martindale R.G., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JParenter Enteral Nutr 2009, 33:277-316.
19. Jakoby M.G., Nannapaneni N. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JParenter Enteral Nutr 2012, 36:183-188.
20. Valero M.A., Leon-Sanz M., Escobar I., et al. Evaluation of non-glucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr 2001, 55:1111-1116.
21. McMahon M.M. Management of parenteral nutrition in acutely ill patients with hyperglycemia. Nutr Clin Pract 2004, 19:120-128.
22. Hongsemeier T., Bistrian B.R. Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. JParenter Enteral Nutr 1993, 17:16-19.
23. Umpierrez G.E., Smiley D., Hermayer K., et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes. Diabetes Care 2013, 36:2169-2174.
24. Smiley D., Umpierrez G.E., Hermayer K., et al. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes. JDiabetes Complications 2013, 27:637-641.
25. Baldwin D., Apel J. Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes. Curr Diabetes Rep 2013, 13:114-120.
26. Donihi A.C., Raval D., Saul M., et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006, 12:358-362.
27. Baker E.H., Janaway C.H., Philips B.J., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006, 61:284-289.
28. Weiser M.A., Cabanillas M.E., Konopleva M., et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 2004, 100:1179-1185.
29. Brunello A., Kapoor R., Extermann M. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol 2011, 34:292-296.
30. Hjelmesaeth J., Harmann A., Leivestad T., et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006, 69:588-595.
31. Braithwaite S.S., Barr W.G., Rahman A., Quddusi S. Managing diabetes during glucocorticoid therapy: how to avoid metabolic emergencies. Postgrad Med 1998, 104:163-166.
32. Burt M.G., Roberts G.W., Aguilar-Loza N.R., et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. JClin Endocrinol Metab 2011, 96:1789-1796.
33. Seggelke S.A., Gibbs J., Draznin B. Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. JHosp Med 2011, 6:175-176.
34. Dhital S.M., Shenker Y., Meredith M., Davis D.B. Aretrospective study comparing neutral protamine Hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients. Endocr Pract 2012, 18:712-719.
35. Gosmanov A.R., Goorha S., Stelts S., et al. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. Endocr Pract 2013, 19:231-235.